Ftse Mib
34.547,70
-0,16%
DAX
18.689,04
-0,20%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
70.110,80
-0,03%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ RenovoRx Inc (RNXT) RenovoRx Inc (RNXT) Notizie

RenovoRx Inc

RNXT
1,35
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/5/202415:00BWPublication of Results of Pre-Clinical Studies Support..
14/5/202415:00BWRenovoRx to Participate in Fireside Chat at the A.G.P...
13/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/5/202423:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202422:50EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/5/202422:47EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202415:00BWRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital..
18/4/202414:30BWRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity..
16/4/202414:30BWRenovoRx Highlights Recent Presentation of Clinical Data..
15/4/202414:00BWRenovoRx Closes $11.1 Million Private Placement, Providing..
08/4/202414:30BWRenovoRx Announces $11.1 Million at Market Private Placement
05/4/202414:30BWRenovoRx to Present at the Canaccord Genuity Horizons in..
12/3/202414:00BWRenovoRx to Present at the 36th Annual ROTH Conference on..
08/3/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:05BWRenovoRx Highlights Key Leadership Promotions
13/2/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:30EDGAR2Form 8-K - Current report
06/2/202414:30BWRenovoRx CEO Issues Letter to Shareholders
31/1/202401:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202415:06EDGAR2Form 8-K - Current report
29/1/202414:30BWRenovoRx Closes $6.1 Million Private Placement
24/1/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:30EDGAR2Form 8-K - Current report
21/12/202314:30BWRenovoRx Engages Oklahoma University (OU) Health as First..
19/12/202314:30BWRenovoRx Announces Clinical Data Abstract at the 2024..
18/12/202322:15EDGAR2Form 8-K - Current report
13/12/202314:31BWRenovoRx Files New International Patent for Novel Targeted..
27/11/202319:23EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202323:30EDGAR2Form PRE 14A - Other preliminary proxy statements
16/11/202314:35BWRenovoRx Expands Scientific Advisory Board with Appointment..
14/11/202314:30BWRenovoRx Reports Third Quarter 2023 Financial Results and..
13/11/202322:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:15EDGAR2Form 8-K - Current report
04/10/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202314:30BWRenovoRx to Present at the ROTH MKM Healthcare Opportunities..
25/8/202322:15EDGAR2Form 8-K - Current report
17/8/202314:30EDGAR2Form 8-K - Current report
17/8/202314:30BWRenovoRx Reports Second Quarter 2023 Financial Results and..
16/8/202320:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/8/202321:57EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
31/7/202314:30BWRenovoRx to Present at the 43rd Annual Canaccord Genuity..
20/7/202314:00BWRenovoRx and Imugene Announce Collaboration to Deliver..
Apertura: Min: Max:
Chiusura: 1,35

La tua Cronologia

NASDAQ
RNXT
RenovoRx
BIT
F30423
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network